Pharmstandard International S.A.

Q4 2016 13F Holdings Report, Stock Holdings

Signature - Title
Eriks Martinovskis - Director
Location
Luxembourg, Luxembourg
Holdings as of
31 Dec 2016
Value $
$88,729,000
Num holdings
3
Filing time
13 Feb 2017, 20:02:27 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included ARGS, PTGX, and PRTO.
Next filing
Q1 2017 - 17 Aug 2017
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Eriks Martinovskis Director Luxembourg, Luxembourg 10 Feb 2017

Other Included Managers (1):

Num Name Location File Number
1 Public Joint Stock Co Pharmstandard